Skip to main content

Over-the-counter medicine

Docosanol Brand names: Abreva

Docosanol (Abreva) is an over-the-counter medicine with an FDA approval on record since 2000. FDA's NDC Directory lists it from 41 generic labelers, and pharmacies paid $5.79 per gram (Docosanol 10% cream) in the October 7, 2026 NADAC survey.

  • Generic listed
  • Over the counter

Check it at the source: the docosanol FDA label on DailyMed (effective June 20, 2024, Haleon US Holdings LLC); the NDA 20941 record on Drugs@FDA; every docosanol label on DailyMed.

Highlights of the record

FDA label of June 20, 2024; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026; NADAC October 7, 2026

Used for

From the label: indications and usage

treats cold sores/fever blisters on the face or lips shortens healing time and duration of symptoms: tingling, pain, burning, and/or itching

Forms and strengths

  • 100 mg/g

Cream.

On the market

Earliest approval on file
July 25, 2000 Abreva, Haleon Us Holdings; Drugs@FDA’s file, where older or withdrawn approvals can be missing
Generic approvals
8 first November 19, 2018; 8 with a marketed status in Drugs@FDA
Labelers listed (NDC)
41 of which 41 under generic applications, 1 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
$5.79 per gram Docosanol 10% cream
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
No recall recorded
FAERS reports
14,572 through July 30, 2026

What is docosanol used for?

From the label: indications and usage

treats cold sores/fever blisters on the face or lips shortens healing time and duration of symptoms: tingling, pain, burning, and/or itching

Source: FDA drug label (ABREVA), Haleon US Holdings LLC, effective June 20, 2024 (SPL set c39b38a7-dcdd-4c32-8f35-b565c4d3cec6), via openFDA; the full label on DailyMed

Is there a generic for docosanol (Abreva)?

The FDA approved the first generic docosanol on November 19, 2018. 8 generic applications are approved; 8 of them carry a current (not discontinued) marketing status in Drugs@FDA; that status is not evidence that the generic is on sale.

FDA's NDC Directory lists docosanol from 41 labelers under a generic (ANDA) application and from 1 brand labeler. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.

  • 2000 earliest approval on file
  • 2018 first generic approved

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What do pharmacies pay for docosanol (Abreva)?

In CMS's NADAC survey of October 7, 2026, pharmacies paid $5.79 per gram (Docosanol 10% cream), down 17% from $6.99 on October 8, 2025. The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.

  • Docosanol 10% cream (generic)
$7.03
$5.38
January 2024October 2026
NADAC per unit, October 7, 2026
Strength and formBrand or genericPharmacy cost30 tablets, or one pen or vial12-month change
Docosanol 10% creamGeneric$5.79 per gramn/a-17%
Ft docosanol 10% creamGeneric$5.79 per gramn/a-17%
Gnp docosanol 10% creamGeneric$5.79 per gramn/a-17%

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

What do FAERS reports show for docosanol?

The FDA Adverse Event Reporting System holds 14,572 reports that list docosanol among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 9 are coded as a death and 133 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

Reports received each year

The most reported reactions

  • Drug Ineffective (a use or a product term, not a reaction)7,060
  • Oral Herpes2,456
  • Condition Aggravated (a use or a product term, not a reaction)1,965
  • Drug Administration Error1,779
  • Incorrect Drug Administration Duration803
  • Herpes Simplex706
  • Incorrect Product Administration Duration639
  • Lip Swelling559

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Docosanol side effects
the label's list beside FAERS reports
Check an interaction
what two or more labels say about each other